TÜV Rheinland: Notified Body for In-Vitro Diagnostics
A lot to be done until the IVDR becomes effective
“By the time enforcement of the new regulation will begin in May 2022, the Notified Bodies will have to test a large number of in-vitro diagnostics manufacturers that are to be certified for the first time and with them a flood of technical documentation,” explains Dr. Hartung. “Even if the year 2022 still seems a long way off, we have already learned with the European Medical Device Directive MDR that manufacturers must adapt to the new requirements at a very early stage. This includes the early involvement of a Notified Body for the IVDR”.
With almost 40 years of experience in in-vitro diagnostic device assessments, TÜV Rheinland is one of the most trusted independent testing service providers for major global brands. More information is available at www.tuv.com/en/IVDR at TÜV Rheinland.
TÜV Rheinland stands for safety and quality in almost all areas of business and life. Founded almost 150 years ago, the company is one of the world’s leading testing service providers with more than 21,400 employees and annual revenues of 2.1 billion euros. TÜV Rheinland’s highly qualified experts test technical systems and products around the world, support innovations in technology and business, train people in numerous professions and certify management systems according to international standards. In doing so, the independent experts generate trust in products as well as processes across global value-adding chains and the flow of commodities. Since 2006, TÜV Rheinland has been a member of the United Nations Global Compact to promote sustainability and combat corruption. Website: www.tuv.com
TÜV Rheinland
Am Grauen Stein
51105 Köln
Telefon: +49 (221) 806-2148
http://www.tuv.com
Pressesprecher Produkte und Academy & Life Care
Telefon: +49 (221) 806-1972
Fax: +49 (221) 806-1358
E-Mail: ralf.diekmann@de.tuv.com
